| 2009.127.B - Metastatic Breast or Prostate Cancer, or Multiple Myeloma With Bone Involvement and the effects of Zoledronic Acid
|
| This randomized phase III trial is studying two different schedules of zoledronic acid to compare how well they work in treating patients with metastatic breast cancer, metastatic prostate cancer, or multiple myeloma with bone involvement. |
| |
| 2010.012B - Breast Cancer and the Effects of Paclitaxel, Carboplatin, and Panitumumab
|
| This phase II trial is studying the side effects and how well paclitaxel and carboplatin together with panitumumab works in treating patients with metastatic triple negative breast cancer. |
| |
| 2010.040.N - NSABP B-43 - Ductal Carcinoma In Situ and the effects of Radiation Therapy with or without Trastuzumab
|
| This randomized phase III trial is studying radiation therapy to see how well it works compared with or without trastuzumab in treating women with ductal carcinoma in situ who have undergone lumpectomy. |
| |
| 2011.005.A Invasive Breast Cancer and the Use of F-18-FLT to Help Predict Tumor Changes
|
| When [F-18] FLT is used during positron emission tomography (PET) imaging, it may produce images that will provide useful information about the tumor's response to treatment. It is hoped that [F-18] FLT PET imaging performed before and during the course of your chemotherapy treatments will help to monitor your tumor status and show whether your tumor is growing or shrinking. |
| |
| 2011.047.A - Breast Cancer and the Effects of Capecitabine
|
| The objective of this phase-III trial is to compare the efficacy and safety of sorafenib in combination with capecitabine versus capecitabine in combination with placebo in the treatment of subjects with locally advanced or metastatic HER2-negative breast cancer who are resistant to or have failed prior taxane and an anthracycline or for whom further anthracycline therapy is not recommended. |
| |
| 2011.054.N - Invasive Breast Cancer and the effects of Trastuzumab
|
| This randomized phase III clinical trial is studying chemotherapy with or without trastuzumab after surgery to see how well they work in treating women with invasive breast cancer. |
| |
| 2011.188.N - S1007- Invasive Breast Cancer and the effects of Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane
|
| A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and Her2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less Greg Bizette, M.D. 2011.188.N Open to new patients 3 This phase III clinical tr |
| |
| 2012.092.B - Breast Cancer and the Effects of Genetic Susceptibility to Radiation-Induced Skin Reactions
|
| This clinical trial studies genetic susceptibility to radiation-induced skin reactions in racial/ethnic groups of patients with breast cancer. |
| |